ArticleScientific reports2025
A comparative analysis of mRNA enrichment strategies and guidance for improving their efficiency.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Proteogenomics: decoding cancer in multiple dimensions.MedScience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The pervasive presence of ribosomal RNA (rRNA) in total RNA poses a considerable challenge to the accurate analysis of cellular transcriptomes. In this study, we comprehensively analyze strategies for Saccharomyces cerevisiae mRNA enrichment, aiming to either separate polyadenylated RNAs or selectively remove rRNAs. Our findings reveal that a single round of mRNA enrichment in recommended conditions proves insufficient for both methods, prompting the exploration of strategies to enhance their efficiency. We show that adjusting the oligo (dT) magnetic beads-to-RNA ratio leads to significant improvement, but even better results can be achieved with two rounds of mRNA enrichment. We propose experimental conditions that reduce rRNA content in total yeast RNA to less than 10%, as confirmed by capillary electrophoresis and NG sequencing. Based on the obtained data, we selected the most time- and cost-effective option of polyadenylated RNA selection in yeast total RNA. Furthermore, we demonstrate that RNA modification with SHAPE reagent (NAI) does not interfere with the optimized mRNA enrichment protocol. These insights contribute to mRNA enrichment strategies and underscore the importance of optimizing mRNA isolation methodologies for downstream analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.